{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:23:11Z","timestamp":1792174991331,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.medcli.2024.03.025","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T11:29:56Z","timestamp":1717673396000},"page":"294-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Feocromocitoma y su abordaje preoperatorio"],"prefix":"10.1016","volume":"163","author":[{"given":"Marta","family":"Araujo-Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.03.025_bib0210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1515\/enr-2017-0018","article-title":"Pheochromocytoma, diagnosis and treatment: Review of the literature","volume":"51","author":"Farrugia","year":"2017","journal-title":"Endocr Regul."},{"key":"10.1016\/j.medcli.2024.03.025_bib0215","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2024.03.025_bib0220","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2024.03.025_bib0225","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40200-016-0226-x","article-title":"Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms","volume":"15","author":"Pourian","year":"2016","journal-title":"J Diabetes Metab Disord."},{"key":"10.1016\/j.medcli.2024.03.025_bib0230","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s40618-021-01649-7","article-title":"Protocol for presurgical and anesthetic management of pheochromocytomas and sympathetic paragangliomas: a multidisciplinary approach","volume":"44","author":"Araujo-Castro","year":"2021","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.medcli.2024.03.025_bib0235","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and Paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2024.03.025_bib0240","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0042-100911","article-title":"Clinical and Pathological Characteristics of Hypertensive and Normotensive Adrenal Pheochromocytomas","volume":"124","author":"Lu","year":"2016","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.1016\/j.medcli.2024.03.025_bib0245","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/BF02067379","article-title":"The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma","volume":"16","author":"Ito","year":"1992","journal-title":"World J Surg."},{"key":"10.1016\/j.medcli.2024.03.025_bib0250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0004563217739931","article-title":"Clinical evaluation and treatment of phaeochromocytoma","volume":"55","author":"Davison","year":"2018","journal-title":"Ann Clin Biochem."},{"key":"10.1016\/j.medcli.2024.03.025_bib0255","first-page":"14","article-title":"Pheochromocytoma\/paraganglioma-associated cardiomyopathy","author":"Szatko","year":"2023","journal-title":"Front Endocrinol (Lausanne)."},{"key":"10.1016\/j.medcli.2024.03.025_bib0260","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/ERC-22-0218","article-title":"Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas","volume":"29","author":"Araujo-Castro","year":"2022","journal-title":"Endocr Relat Cancer."},{"key":"10.1016\/j.medcli.2024.03.025_bib0265","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1097\/00004872-200309000-00020","article-title":"Diabetes as a marker of pheochromocytoma in hypertensive patients","volume":"21","author":"La Batide-Alanore","year":"2003","journal-title":"J Hypertens."},{"key":"10.1016\/j.medcli.2024.03.025_bib0270","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.medcli.2024.03.025_bib0275","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the Patient With Adrenal Incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2024.03.025_bib0280","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1038\/s41598-022-06655-0","article-title":"Predictive model of pheochromocytoma based on the imaging features of the adrenal tumours","volume":"12","author":"Araujo-Castro","year":"2022","journal-title":"Sci Rep."},{"key":"10.1016\/j.medcli.2024.03.025_bib0285","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0029-1237699","article-title":"False positive test results for pheochromocytoma from 2000 to 2008","volume":"118","author":"Yu","year":"2010","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"10.1016\/j.medcli.2024.03.025_bib0290","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary metanephrines: Implications for diagnosis of catecholamine-producing tumors","volume":"94","author":"De Jong","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2024.03.025_bib0295","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: How to distinguish true- from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2024.03.025_bib0300","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/cen.14724","article-title":"Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use","volume":"97","author":"Tsiomidou","year":"2022","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.medcli.2024.03.025_bib0305","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/00045632231154731","article-title":"Establishment of reference intervals for plasma metanephrines in seated position measured by LC-MS\/MS and assessment of diagnostic performance in pheochromocytoma\/paraganglioma","volume":"60","author":"Lin","year":"2023","journal-title":"Ann Clin Biochem."},{"key":"10.1016\/j.medcli.2024.03.025_bib0310","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cca.2018.12.019","article-title":"Reference intervals for LC-MS\/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine","volume":"490","author":"Eisenhofer","year":"2019","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.medcli.2024.03.025_bib0315","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.eprac.2020.09.011","article-title":"Chromogranin A in a Cohort of Pheochromocytomas and Paragangliomas: Usefulness at Diagnosis and as an Early Biomarker of Recurrence","volume":"27","author":"Parisien-La Salle","year":"2021","journal-title":"Endocr Pract."},{"key":"10.1016\/j.medcli.2024.03.025_bib0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1258\/acb.2012.012112","article-title":"Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamineproducing metastatic phaeochromocytoma","volume":"50","author":"Peitzsch","year":"2013","journal-title":"Ann Clin Biochem."},{"key":"10.1016\/j.medcli.2024.03.025_bib0325","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/cen.12745","article-title":"Diagnosing phaeochromocytoma\/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging","volume":"83","author":"Amar","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.medcli.2024.03.025_bib0330","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.endinu.2021.09.013","article-title":"Role of imaging test with radionuclides in the diagnosis and treatment of pheochromocytomas and paragangliomas","volume":"69","author":"Araujo-Castro","year":"2022","journal-title":"Endocrinol Diabetes Nutr."},{"key":"10.1016\/j.medcli.2024.03.025_bib0335","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: A position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens."},{"key":"10.1016\/j.medcli.2024.03.025_bib0340","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.medcli.2024.03.025_bib0345","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and Phaeochromocytoma: From Genetics to Personalized Medicine","volume":"11","author":"Favier","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"10.1016\/j.medcli.2024.03.025_bib0350","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1159\/000529319","article-title":"Genetic study in pheochromocytoma: is it possible to stratify the risk of hereditary pheochromocytoma?","volume":"113","author":"Araujo-Castro","year":"2023","journal-title":"Neuroendocrinology."},{"key":"10.1016\/j.medcli.2024.03.025_bib0355","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.medcli.2024.03.025_bib0360","doi-asserted-by":"crossref","DOI":"10.1177\/20420188231207544","article-title":"Pheochromocytoma: a changing perspective and current concepts","volume":"14","author":"Kiriakopoulos","year":"2023","journal-title":"Ther Adv Endocrinol Metab."},{"key":"10.1016\/j.medcli.2024.03.025_bib0365","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1002\/bjs.10744","article-title":"Extent of Surgery for Phaeochromocytomas in the Genomic Era","volume":"105","author":"Rossitti","year":"2018","journal-title":"Br J Surg."},{"key":"10.1016\/j.medcli.2024.03.025_bib0370","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/cancers11081070","article-title":"Pheochromocytomas and Paragangliomas: New Developments with Regard to Classification, Genetics, and Cell of Origin","volume":"11","author":"Koopman","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.medcli.2024.03.025_bib0375","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1002\/bjs.11348","article-title":"Meta-Analysis of \u03b1-Blockade versus No Blockade before Adrenalectomy for Phaeochromocytoma","volume":"107","author":"Schimmack","year":"2020","journal-title":"Br J Surg."},{"key":"10.1016\/j.medcli.2024.03.025_bib0380","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1002\/bjs.11378","article-title":"International multicentre review of perioperative management and outcome for catecholamine-producing tumours","volume":"107","author":"Groeben","year":"2020","journal-title":"Br J Surg."},{"key":"10.1016\/j.medcli.2024.03.025_bib0385","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s40618-022-01954-9","article-title":"Differences in intraoperative and surgical outcomes between normotensive pheochromocytomas and sympathetic paragangliomas (PPGLs) and hypertensive PPGLs: results from the PHEO-RISK STUDY","volume":"46","author":"Araujo-Castro","year":"2023","journal-title":"J Endocrinol Invest."},{"key":"10.1016\/j.medcli.2024.03.025_bib0390","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1210\/clinem\/dgaa441","article-title":"Approach to the Patient: Perioperative Management of the Patient with Pheochromocytoma or Sympathetic Paraganglioma","volume":"105","author":"Berends","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2024.03.025_bib0395","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1210\/clinem\/dgz188","article-title":"Efficacy of \u03b1-blockers on hemodynamic control during pheochromocytoma resection: A randomized controlled trial","volume":"105","author":"Buitenwerf","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.medcli.2024.03.025_bib0400","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2044.2005.04156.x","article-title":"The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas","volume":"60","author":"Lebuffe","year":"2005","journal-title":"Anaesthesia."},{"key":"10.1016\/j.medcli.2024.03.025_bib0405","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2265.2006.02571.x","article-title":"Phaeochromocytomas presenting as acute crises after beta blockade therapy","volume":"65","author":"Sibal","year":"2006","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.medcli.2024.03.025_bib0410","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000074659","article-title":"Biochemical diagnosis of pheochromocytoma","volume":"31","author":"Eisenhofer","year":"2004","journal-title":"Front Horm Res."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324002860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324002860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T18:23:27Z","timestamp":1726597407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324002860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0025775324002860"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.03.025","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feocromocitoma y su abordaje preoperatorio","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.03.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}